Christopher Posner
Director, Tvardi Therapeutics, Inc.
Companies
- Tvardi Therapeutics, Inc.President Mar 1, 2022 to now1
- Tvardi Therapeutics, Inc.Board member Aug 6, 2018 to now2
- Tvardi Therapeutics, Inc.Chief executive officer Mar 1, 2022 to Apr 17, 20251
- ZEVRA THERAPEUTICS, INC.Board member Nov 30, 2022 to Nov 30, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tvardi Therapeutics, Inc. TVRD13,109 shares4$14.0K at $1.06Feb 28, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 28, 2025Sold 583 shares at $4.75 of Tvardi Therapeutics, Inc.4
- Feb 4, 2025Sold 372 shares at $4.72 of Tvardi Therapeutics, Inc.5
- Nov 4, 2024Sold 3,668 shares at $0.29 of Tvardi Therapeutics, Inc.6
- Aug 1, 2024Sold 4,149 shares at $0.35 of Tvardi Therapeutics, Inc.7
- May 2, 2024Sold 3,936 shares at $0.75 of Tvardi Therapeutics, Inc.8
- Feb 29, 2024Sold 5,834 shares at $0.89 of Tvardi Therapeutics, Inc.9
- Feb 8, 2024Sold 35,575 shares at $0.53 of Tvardi Therapeutics, Inc.10
- Feb 1, 2024Sold 4,981 shares at $0.55 of Tvardi Therapeutics, Inc.11
- Feb 1, 2024Granted 62,500 shares of Tvardi Therapeutics, Inc.11
- Nov 2, 2023Sold 3,796 shares at $1.22 of Tvardi Therapeutics, Inc.12
- Aug 3, 2023Sold 4,307 shares at $3.07 of Tvardi Therapeutics, Inc.13
- May 5, 2023Sold 3,869 shares at $4.40 of Tvardi Therapeutics, Inc.14
- Mar 3, 2023Sold 5,987 shares at $9.71 of Tvardi Therapeutics, Inc.15
- Feb 2, 2023Sold 4,191 shares at $11.80 of Tvardi Therapeutics, Inc.16
- Nov 16, 2022Sold 14,470 shares at $11.13 of Tvardi Therapeutics, Inc.17
- Apr 4, 2022Sold 2,006 shares at $12.67 of Tvardi Therapeutics, Inc.18
- Feb 25, 2022Granted 39,000 shares of Tvardi Therapeutics, Inc.19
- Oct 29, 2021Granted 142,000 shares of Tvardi Therapeutics, Inc.20
- Oct 29, 2021Granted 5,941 shares of Tvardi Therapeutics, Inc.20
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARTvardi Therapeutics, Inc., President
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Feb 6, 2025
- 6SEC EDGARForm 4 filed Nov 6, 2024
- 7SEC EDGARForm 4 filed Aug 2, 2024
- 8SEC EDGARForm 4 filed May 6, 2024
- 9SEC EDGARForm 4 filed Mar 4, 2024
- 10SEC EDGARForm 4 filed Feb 12, 2024
- 11SEC EDGARForm 4 filed Feb 5, 2024
- 12SEC EDGARForm 4 filed Nov 3, 2023
- 13SEC EDGARForm 4 filed Aug 4, 2023
- 14SEC EDGARForm 4 filed May 9, 2023
- 15SEC EDGARForm 4 filed Mar 7, 2023
- 16SEC EDGARForm 4 filed Feb 3, 2023
- 17SEC EDGARForm 4 filed Nov 18, 2022
- 18SEC EDGARForm 4 filed Apr 5, 2022
- 19SEC EDGARForm 4 filed Mar 1, 2022
- 20SEC EDGARForm 4 filed Nov 3, 2021